openPR Logo
Press release

Creative Peptides Released GMP Synthesis Service

09-04-2018 10:06 AM CET | Health & Medicine

Press release from: Creative Peptides

Located in Shirley, New York, the world’s leading peptide supplier Creative Peptides announced the launch of its GMP synthesis (https://www.creative-peptides.com/services/custom-gmp-peptide-synthesis-services.html ) business on August 29, 2018. Now this company is focused on the development and GMP manufacturing of pharmaceutical grade peptides.
As the demand of pharmaceutical market continues to grow, more and more pharmas and research institutions choose the CMO and CRO models to expand their businesses, which is more cost-saving, efficient without additional expenses on staff, equipment and other infrastructure. Creative Peptides has become the first choice to outsource the manufacturing of peptides or active pharmaceutical ingredients (APIs) in any quantities, owing to its world-in-class technologies, strong technical staff and strict quality control systems.
“We are able to produce GMP peptides, APIs in annual quantities as needed by our customers. The availability of low-cost active pharmaceutical ingredients from our company has had a big impact in the international community,” said Dr. Robert Martinez, Head of Creative Peptides’ synthesis businesses, in a statement. “Our robust, economical manufacturing processes will definitely help optimize the costs of drug discovery and development. A full range of synthetic technologies are available. But as to which technology to be used, the final choice depends on the sequence length, the scale, and the specific project requirements.”
The GMP synthesis range at Creative Peptides includes:
Large-Scale Liquid (Solution) Phase Peptide Synthesis (LPPS)
Large-Scale Solid Phase Peptide Synthesis (SPPS)
Large-Scale Hybrid Fragment Synthesis Peptide
Modifications
Large-Scale Purification
Large-Scale Isolation
Whenever and wherever, quality control is the top priority for Creative Peptides. The GMP production sites were designed in strict accordance to US-FDA guidelines. All have passed US-FDA inspections. Currently this company is qualified for the manufacturing of generic APIs in compliance with ICH guidelines including Q7 and other related and applicable sections.
>98% purity of the GMP synthetic products is guaranteed. Standard QC tests before releasing GMP products are also provided. Extra tests can be made as well according to the requests of clients.

About Creative Peptides
With a high profile team of experts in multiple fields such as peptide technology and synthetic chemistry, Creative Peptides not only provides various research peptides, like anti-pigmentation peptide (https://www.creative-peptides.com/product/anti-pigmentation-54.html), neoantigen (https://www.creative-peptides.com/services/neoantigen-peptides-vaccine-synthesis-service.html), glucagon like peptides, but also dedicates to solving the problems that trouble its clients by offering various GMP synthesis services.

Creative Peptides

45-16 Ramsey Road, Shirley, NY 11967, USA

Caroline Miller

contact@creative-peptides.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Creative Peptides Released GMP Synthesis Service here

News-ID: 1217565 • Views:

More Releases from Creative Peptides

Creative Peptides Released One-Stop Solution for All Peptide Drug Conjugate Need …
New York, United States-Sep 5, 2022-Peptide drug conjugate (PDC) is emerging as a novel type of conjugate drug, showing advantageous features over antibody-drug conjugates (ADCs). As a dedicated peptide manufacturer, Creative Peptides provides a one-stop solution for all peptide drug bioconjugation needs to help pharmaceutical clients bring more PDCs to the market. Structurally, PDC mainly contains three elements-cytotoxin, linker, and targeted peptide, in which a specific peptide sequence covalently connects with
Creative Peptides Rolls Out PNA FISH Probes with High Sensitivity and Specific H …
New York, United States - March 22, 2022-Creative Peptides, as a pioneering biomedical technology company in the United States, is qualified to provide highly specific products and services for life science research. To promote PNA biology research, Creative Peptides offers various PNA FISH probes such as telomere probes and CAG repeat probes. Fluorescence in situ hybridization (FISH) is a cytogenetic method to detect and target the presence or absence of specific

More Releases for Peptide

08-11-2026 | Health & Medicine
Getnews
Peptide Pod Launches a New Platform Bringing Peptide Podcasts and Research Toget …
The world's first dedicated peptide podcast platform brings trusted education, research, and leading voices together in one place. United States - August 10, 2026 - As interest in peptides continues to rise, finding trustworthy educational content has become increasingly difficult. New podcasts, research papers, and online discussions appear almost daily, leaving many people searching across multiple websites to stay informed. Peptide Pod [https://peptidepod.com/] is changing that by bringing peptide podcasts, research,
Automated Microwave Peptide Synthesizer Market Innovation: Accelerating High-Thr …
The global Automated Microwave Peptide Synthesizer Market is witnessing robust growth as pharmaceutical companies, biotechnology firms, and research organizations increasingly adopt automated peptide synthesis technologies to accelerate drug discovery and development. Automated microwave peptide synthesizers have transformed peptide manufacturing by significantly reducing synthesis time while improving reaction efficiency, reproducibility, and product quality. As peptide-based therapeutics continue gaining prominence across modern medicine, demand for advanced synthesis platforms is expanding rapidly. According to
Peptide Express Launches Independently HPLC-Verified Research Peptide Catalog
Peptide Express has launched an expanded catalog of 30+ research-grade peptides, each independently tested by third-party laboratories for 99%+ purity. United States, 13th Jul 2026 - Peptide Express has announced the launch of its expanded catalog of research-grade peptides, built for laboratories, academic institutions, and independent researchers who require verifiable documentation of compound identity and purity. The platform gives researchers access to more than 30 research compounds, each independently tested by third-party
Peptide Dropshipping & White Label Peptide Fulfillment Solution Launch | RapidFu …
Image: https://www.globalnewslines.com/uploads/2026/04/a6b799d3d1fc2ae063a8a0793dc74785.jpg Los Angeles, CA - April 16, 2026 - RapidFulfillment.com, a leading 3PL fulfillment provider, today announced the launch of its Peptide Dropshipping Service Partnership, a turnkey white label peptide fulfillment solution designed to help entrepreneurs, eCommerce brands, and B2B operators enter the rapidly growing peptide market-without inventory, infrastructure, or operational complexity. This new service provides a fully integrated, end-to-end system combining U.S.-based peptide sourcing, compliant fulfillment, cold storage logistics, and
Shaping the Cell Penetrating Peptide Market in 2025: Innovative Peptide Drug Dis …
How Big Is the Cell Penetrating Peptide Market Expected to Be, and What Will Its Growth Rate Be? In recent times, the market size for cell penetrating peptides has expanded swiftly. The market is projected to rise from a value of $1.87 billion in 2024 to $2.16 billion in 2025, growing at a compound annual growth rate (CAGR) of 15.6%. The historic period's growth can be credited to an amplified comprehension
Cancer Peptide Drugs Market
Global Peptide Cancer Drug Market Size, Dosage, Drug Price, Sales & Clinical Trials Insight 2030 Report Highlights: • Global Peptide Cancer Drug Market Insight By Region & Indication • Global Peptide Cancer Drug Market Opportunity: > US$ 18 Billion • Approved Peptide Cancer Drugs: > 30 Drugs • Approved Peptide Cancer Drugs Sales Insights, Patent, Dosage and Price Analysis • Peptide Cancer Drugs Clinical Trials Insight By Company, Country, Indication and Phase • Insight On Peptide Cancer Drugs In Clinical Trials: >